172 related articles for article (PubMed ID: 28641844)
1. The In Vivo Morphology of Post-Infarct Ventricular Septal Defect and the Implications for Closure.
Hamilton MCK; Rodrigues JCL; Martin RP; Manghat NE; Turner MS
JACC Cardiovasc Interv; 2017 Jun; 10(12):1233-1243. PubMed ID: 28641844
[TBL] [Abstract][Full Text] [Related]
2. Does the placement of an Amplatzer septal occluder device confer benefit in patients with a post-infarction ventricular septal defect?
Dawson AG; Williams SG; Cole D
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1040-7. PubMed ID: 25193971
[TBL] [Abstract][Full Text] [Related]
3. [Transcatheter closure of postinfarction ventricular septal defects using Amplatzer devices].
Bialkowski J; Szkutnik M; Kusa J; Kalarus Z; Gasior M; Przybylski R; Banaszak P; Zembala M
Rev Esp Cardiol; 2007 May; 60(5):548-51. PubMed ID: 17535768
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Closure of Apical Post-Infarct Septal Defect: Externalizing an Occluder and Excluding the Right Ventricle.
Caughron H; Kamioka N; Saikus CE; Lerakis S; Block P; Babaliaros V; Guyton R
JACC Cardiovasc Interv; 2018 Apr; 11(8):e59-e61. PubMed ID: 29605242
[No Abstract] [Full Text] [Related]
5. Postinfarction Ventricular Septal Defect Closure.
Kamioka N; Lederman RJ; Greenbaum AB; Khan JM; Yousef A; Gleason PT; Grubb KJ; Block PC; Leshnower B; Babaliaros VC
Circ Cardiovasc Interv; 2019 May; 12(5):e007788. PubMed ID: 31088121
[No Abstract] [Full Text] [Related]
6. Percutaneous repair of post-myocardial infarction ventricular septal defect: current approaches and future perspectives.
Baldasare MD; Polyakov M; Laub GW; Costic JT; McCormick DJ; Goldberg S
Tex Heart Inst J; 2014 Dec; 41(6):613-9. PubMed ID: 25593526
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure of postinfarction ventricular septal defect using the Amplatzer atrial septal defect occluder.
Giombolini C; Notaristefano S; Santucci S; Fortunati F; Savino K; Notaristefano F; Santoro G; Ambrosio G
J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):941-5. PubMed ID: 18695436
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter closure of postmyocardial infarction, iatrogenic, and postoperative ventricular septal defects: The Mayo Clinic experience.
Egbe AC; Poterucha JT; Rihal CS; Taggart NW; Cetta F; Cabalka AK; Pollak PM; Reeder GS; Hagler DJ
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1264-70. PubMed ID: 26033272
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Closure of Post-Infarction Ventricular Septal Defects-An Over Decade-long Experience.
Sabiniewicz R; Huczek Z; Zbroński K; Scisło P; Rymuza B; Kochman J; Marć M; Grygier M; Araszkiewicz A; Dziarmaga M; Leśniewicz P; Hiczkiewicz J; Kidawa M; Filipiak KJ; Opolski G
J Interv Cardiol; 2017 Feb; 30(1):63-71. PubMed ID: 28078714
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
Pinto RJ; Dalvi BV; Sharma S
Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
[TBL] [Abstract][Full Text] [Related]
11. Which patients might be suitable for a septal occluder device closure of postinfarction ventricular septal rupture rather than immediate surgery?
Attia R; Blauth C
Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):626-9. PubMed ID: 20621996
[TBL] [Abstract][Full Text] [Related]
12. Closure of post-myocardial infarction ventricular septal defect with use of intracardiac echocardiographic imaging and percutaneous left ventricular assistance.
Loyalka P; Cevik C; Nathan S; Gregoric ID; Kar B
Tex Heart Inst J; 2012; 39(3):454-6. PubMed ID: 22719172
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Intervention to Treat Platypnea-Orthodeoxia Syndrome: The Toronto Experience.
Shah AH; Osten M; Leventhal A; Bach Y; Yoo D; Mansour D; Benson L; Wilson WM; Horlick E
JACC Cardiovasc Interv; 2016 Sep; 9(18):1928-38. PubMed ID: 27659570
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of large postinfarct ventricular septal defect: Initial results of prototype Occlutech® device including the first-in-human.
Lee KT; Taliotis D; Hamilton M; Manghat N; Bedair R; Turner M
Catheter Cardiovasc Interv; 2023 Feb; 101(3):620-627. PubMed ID: 36841941
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study.
Zhu XY; Qin YW; Han YL; Zhang DZ; Wang P; Liu YF; Xu YW; Jing QM; Xu K; Gersh BJ; Wang XZ
EuroIntervention; 2013 Mar; 8(11):1270-6. PubMed ID: 23538156
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter closure of ventricular septal defect with two different devices.
Atik SU; Saltik L
Cardiol Young; 2018 Nov; 28(11):1364-1366. PubMed ID: 30058512
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transcatheter ventricular septal defect closure in adults with Amplatzer septal occluders.
Marinakis A; Vydt T; Dens J; Gewillig M; Van Deyk K; Budts W
Acta Cardiol; 2007 Aug; 62(4):391-5. PubMed ID: 17824300
[TBL] [Abstract][Full Text] [Related]
18. Preliminary experience in the use of CERA occluders for closure of different intracardiac and extracardiac shunts.
Fiszer R; Szkutnik M; Chodor B; Bialkowski J
J Invasive Cardiol; 2014 Aug; 26(8):385-8. PubMed ID: 25091098
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous ventricular septal defect closure with Amplatzer devices resulting in severe tricuspid regurgitation.
Matyal R; Wang A; Mahmood F
Catheter Cardiovasc Interv; 2013 Nov; 82(6):E817-20. PubMed ID: 23553968
[TBL] [Abstract][Full Text] [Related]
20. UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults.
Smith B; Thomson J; Crossland D; Spence MS; Morgan GJ
Catheter Cardiovasc Interv; 2014 Mar; 83(4):581-6. PubMed ID: 24115686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
